Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds, Nonpenetrating | 3 | 2016 | 103 | 1.330 |
Why?
|
| Laparoscopy | 8 | 2022 | 401 | 0.800 |
Why?
|
| Pancreas | 2 | 2016 | 146 | 0.610 |
Why?
|
| Abdominal Injuries | 1 | 2016 | 30 | 0.520 |
Why?
|
| Wounds, Penetrating | 1 | 2012 | 24 | 0.390 |
Why?
|
| Spleen | 1 | 2012 | 486 | 0.360 |
Why?
|
| Infant | 9 | 2022 | 1532 | 0.340 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2009 | 11 | 0.330 |
Why?
|
| Dextrans | 1 | 2009 | 44 | 0.330 |
Why?
|
| Child | 14 | 2021 | 4332 | 0.330 |
Why?
|
| Hernia, Inguinal | 2 | 2022 | 38 | 0.330 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 64 | 0.320 |
Why?
|
| Hyaluronic Acid | 1 | 2009 | 64 | 0.320 |
Why?
|
| Intestinal Obstruction | 2 | 2012 | 50 | 0.310 |
Why?
|
| Appendicitis | 3 | 2018 | 75 | 0.290 |
Why?
|
| Retrospective Studies | 14 | 2022 | 6136 | 0.290 |
Why?
|
| Child, Preschool | 9 | 2018 | 1850 | 0.290 |
Why?
|
| Internship and Residency | 3 | 2024 | 748 | 0.280 |
Why?
|
| Injury Severity Score | 2 | 2016 | 102 | 0.250 |
Why?
|
| Gift Giving | 1 | 2024 | 8 | 0.230 |
Why?
|
| Adolescent | 9 | 2018 | 5957 | 0.220 |
Why?
|
| Infant, Newborn | 5 | 2022 | 1312 | 0.220 |
Why?
|
| Meckel Diverticulum | 1 | 2003 | 3 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 1481 | 0.210 |
Why?
|
| Pyloric Stenosis | 1 | 2002 | 4 | 0.200 |
Why?
|
| Fundoplication | 1 | 2002 | 19 | 0.200 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 29 | 0.200 |
Why?
|
| Fetal Diseases | 1 | 2002 | 21 | 0.200 |
Why?
|
| Interviews as Topic | 1 | 2024 | 495 | 0.200 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2002 | 12 | 0.200 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2002 | 43 | 0.200 |
Why?
|
| Hepatoblastoma | 1 | 2002 | 8 | 0.200 |
Why?
|
| Anesthesia, Spinal | 1 | 2022 | 28 | 0.200 |
Why?
|
| Musa | 1 | 2021 | 7 | 0.190 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2021 | 8 | 0.190 |
Why?
|
| Pyloromyotomy | 1 | 2021 | 6 | 0.190 |
Why?
|
| General Surgery | 1 | 2024 | 193 | 0.190 |
Why?
|
| Cisplatin | 1 | 2002 | 119 | 0.190 |
Why?
|
| Doxorubicin | 1 | 2002 | 99 | 0.190 |
Why?
|
| Treatment Outcome | 10 | 2022 | 5264 | 0.190 |
Why?
|
| Humans | 25 | 2024 | 60093 | 0.190 |
Why?
|
| Femoral Artery | 1 | 2002 | 94 | 0.180 |
Why?
|
| Education, Medical, Graduate | 2 | 2024 | 319 | 0.180 |
Why?
|
| Suture Techniques | 2 | 2019 | 86 | 0.180 |
Why?
|
| Female | 17 | 2024 | 31229 | 0.180 |
Why?
|
| Male | 16 | 2024 | 27963 | 0.180 |
Why?
|
| Renal Dialysis | 1 | 2002 | 186 | 0.180 |
Why?
|
| Length of Stay | 4 | 2015 | 781 | 0.170 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 279 | 0.160 |
Why?
|
| Appendix | 1 | 2018 | 14 | 0.160 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2002 | 282 | 0.160 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 405 | 0.150 |
Why?
|
| Educational Measurement | 1 | 2019 | 213 | 0.150 |
Why?
|
| Ultrasonography | 1 | 2018 | 460 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 928 | 0.130 |
Why?
|
| Thoracic Injuries | 1 | 2016 | 47 | 0.130 |
Why?
|
| Logistic Models | 2 | 2015 | 1260 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2015 | 849 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2019 | 699 | 0.110 |
Why?
|
| Pectus Carinatum | 1 | 2014 | 4 | 0.110 |
Why?
|
| Braces | 1 | 2014 | 10 | 0.110 |
Why?
|
| Child Advocacy | 1 | 2013 | 7 | 0.110 |
Why?
|
| Wounds, Gunshot | 1 | 2013 | 53 | 0.100 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 20 | 0.100 |
Why?
|
| Firearms | 1 | 2013 | 60 | 0.100 |
Why?
|
| Splenectomy | 1 | 2012 | 42 | 0.100 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2012 | 34 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 273 | 0.100 |
Why?
|
| Bites and Stings | 1 | 2011 | 11 | 0.090 |
Why?
|
| Hospital Mortality | 2 | 2013 | 856 | 0.090 |
Why?
|
| Facial Injuries | 1 | 2011 | 14 | 0.090 |
Why?
|
| Appendectomy | 2 | 2018 | 50 | 0.090 |
Why?
|
| Wound Infection | 1 | 2011 | 26 | 0.090 |
Why?
|
| Colectomy | 1 | 2012 | 100 | 0.090 |
Why?
|
| Cicatrix | 1 | 2011 | 58 | 0.090 |
Why?
|
| Sutures | 2 | 2016 | 33 | 0.090 |
Why?
|
| Soft Tissue Infections | 1 | 2011 | 45 | 0.090 |
Why?
|
| Community-Acquired Infections | 1 | 2011 | 88 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2011 | 66 | 0.090 |
Why?
|
| Dogs | 1 | 2011 | 307 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 116 | 0.080 |
Why?
|
| Retreatment | 1 | 2009 | 46 | 0.080 |
Why?
|
| Herniorrhaphy | 2 | 2022 | 65 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2012 | 2477 | 0.080 |
Why?
|
| Laparoscopes | 1 | 2007 | 21 | 0.070 |
Why?
|
| Touch | 1 | 2007 | 28 | 0.070 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 125 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 2614 | 0.060 |
Why?
|
| Thoracoscopy | 1 | 2004 | 23 | 0.060 |
Why?
|
| Personnel Selection | 1 | 2024 | 49 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 406 | 0.060 |
Why?
|
| Postoperative Complications | 3 | 2016 | 1175 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2003 | 75 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2002 | 30 | 0.050 |
Why?
|
| Life Tables | 1 | 2002 | 24 | 0.050 |
Why?
|
| Ligation | 1 | 2022 | 35 | 0.050 |
Why?
|
| Polytetrafluoroethylene | 1 | 2002 | 18 | 0.050 |
Why?
|
| Pylorus | 1 | 2021 | 10 | 0.050 |
Why?
|
| Prosthesis-Related Infections | 1 | 2002 | 33 | 0.050 |
Why?
|
| Gastroesophageal Reflux | 1 | 2002 | 78 | 0.050 |
Why?
|
| Vascular Patency | 1 | 2002 | 132 | 0.050 |
Why?
|
| Educational Status | 1 | 2022 | 273 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2002 | 177 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2013 | 773 | 0.040 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2002 | 211 | 0.040 |
Why?
|
| Formative Feedback | 1 | 2019 | 8 | 0.040 |
Why?
|
| Equipment and Supplies | 1 | 2019 | 17 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2019 | 58 | 0.040 |
Why?
|
| Lung | 1 | 2004 | 842 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 126 | 0.040 |
Why?
|
| Incidence | 2 | 2013 | 1266 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 2501 | 0.040 |
Why?
|
| Age Factors | 2 | 2013 | 1526 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 629 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 2360 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2016 | 103 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 1470 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 197 | 0.030 |
Why?
|
| Wound Healing | 1 | 2016 | 177 | 0.030 |
Why?
|
| Curriculum | 1 | 2019 | 570 | 0.030 |
Why?
|
| Pregnancy | 1 | 2002 | 2359 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 930 | 0.030 |
Why?
|
| Massachusetts | 1 | 2019 | 2119 | 0.030 |
Why?
|
| Ovarian Cysts | 1 | 2012 | 5 | 0.030 |
Why?
|
| Hospital Charges | 1 | 2012 | 23 | 0.030 |
Why?
|
| Urban Population | 1 | 2013 | 185 | 0.030 |
Why?
|
| Young Adult | 2 | 2013 | 4394 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 48 | 0.020 |
Why?
|
| Neutropenia | 1 | 2012 | 66 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 558 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 257 | 0.020 |
Why?
|
| Soft Tissue Injuries | 1 | 2011 | 19 | 0.020 |
Why?
|
| Unnecessary Procedures | 1 | 2011 | 42 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 15980 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 50 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2014 | 373 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 483 | 0.020 |
Why?
|
| Operating Rooms | 1 | 2011 | 54 | 0.020 |
Why?
|
| Poverty | 1 | 2013 | 293 | 0.020 |
Why?
|
| Emergencies | 1 | 2011 | 114 | 0.020 |
Why?
|
| Drainage | 1 | 2011 | 150 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 255 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 262 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 790 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 661 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 970 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 170 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2011 | 229 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2078 | 0.020 |
Why?
|
| Animals | 3 | 2016 | 19752 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 910 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1564 | 0.020 |
Why?
|
| United States | 2 | 2013 | 7608 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 1934 | 0.020 |
Why?
|
| Equipment Design | 1 | 2007 | 318 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 735 | 0.020 |
Why?
|
| Middle Aged | 1 | 2002 | 16540 | 0.020 |
Why?
|
| Insufflation | 1 | 2004 | 10 | 0.010 |
Why?
|
| Pressure | 1 | 2004 | 75 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 222 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 349 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 376 | 0.010 |
Why?
|